EUVIMEDSkopri EUVIMED
Open access

Effectiveness of Topiramate in Medically Complicated Patients with Status Epilepticus or Acute Refractory Seizures

Woojun Kim, Se Yoon Kwon, A Hyun Cho, Sung Chul Lim, Yeong In Kim, Young-Min Shon

Journal of Epilepsy Research · 2011

DOI: 10.14581/jer.11010 ↗

At a glance

Journal article in Journal of Epilepsy Research, 2011. Written by Woojun Kim and 5 co-authors. Institution: Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang;. Cited 6 times so far (Crossref); 17 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

BACKGROUND AND PURPOSE: The conventional therapeutic regimen for status epilepticus (SE) may require artificial ventilation and hemodynamic support, and is associated with significant complications and increased mortality. We investigated the safety and effectiveness of topiramate (TPM) in patients with refractory SE, who had medical complications such as systemic infection, renal dysfunction, hepatic dysfunction, and bone marrow suppression. METHODS: We analyzed the clinical features and therapeutic outcome in 16 patients with GCSE, NCSE or recurrent GTC in whom TPM was administered for its control. RESULTS: The majority of our patients had GCSE (n=6) or NCSE (n=7). The common co-morbid diseases at the onset of seizures were hematological disorders (pancytopenia 8, anemia 2, anemia with thrombocytopenia 2) and sepsis (n=8). Twelve patients were under the renal and/or hepatic dysfunction. Within a few days, 13 patients could experience their seizure control (the mean duration, 3.7± 2.6 days), but the seizures of the other subjects did not be terminated in spite of all efforts. No patients experienced a worsening of their CBC or blood chemistry profiles with the TPM treatment. CONCLUSIONS: We could confirm that TPM was not only safe but very effective for the control of recurrent epileptic seizures or SE in patients with serious medical co-morbidities. TPM may be considered as another treatment option when conventional protocols are ineffective.

Subjects

Author keywords

Recurrent seizuresStatus epilepticusTopiramate

Authors and institutions

  • Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang;
  • Department of Neurology, The Catholic University of Korea, Seoul, Korea.

Cite

APA

Kim, W., Kwon, S. Y., Cho, A. H., Lim, S. C., Kim, Y. I., & Shon, Y. M. (2011). Effectiveness of Topiramate in Medically Complicated Patients with Status Epilepticus or Acute Refractory Seizures. Journal of Epilepsy Research. https://doi.org/10.14581/jer.11010

Vancouver

Kim W, Kwon SY, Cho AH, Lim SC, Kim YI, Shon YM. Effectiveness of Topiramate in Medically Complicated Patients with Status Epilepticus or Acute Refractory Seizures. Journal of Epilepsy Research. 2011. doi:10.14581/jer.11010

BibTeX
@article{Kim2011,
  author = {Kim, Woojun and Kwon, Se Yoon and Cho, A Hyun and Lim, Sung Chul and Kim, Yeong In and Shon, Young-Min},
  title = {Effectiveness of Topiramate in Medically Complicated Patients with Status Epilepticus or Acute Refractory Seizures},
  journal = {Journal of Epilepsy Research},
  year = {2011},
  doi = {10.14581/jer.11010}
}
Start for free →